Wednesday, June 10, 2026

Patent intelligence · US

US 2010247626

PEGYLATED COMPOUNDS FOR AGE-RELATED MACULAR DEGENERATION

granted A61K 9/ 00 A IA61K 9/ 127 A IA61K 31/ 409 A IA61K 41/ 00 A I
Status granted
Linked drugs 1
Pipeline programs 6
Years to expiry 4
Applicant portfolio 25
Patent details — US 2010247626
Jurisdiction
US
Status
granted
Grant date
Sep 30, 2010
Expiration
Sep 25, 2030
CPC classes
A61K 9/ 00 A I, A61K 9/ 127 A I, A61K 31/ 409 A I, A61K 41/ 00 A I
View on Google Patents ↗

Quick answer

US 2010247626 (PEGYLATED COMPOUNDS FOR AGE-RELATED MACULAR DEGENERATION) is held by ALBRECHT VOLKER [DE]. Status: granted. Granted Sep 30, 2010. Expires Sep 25, 2030 (4 years remaining) — relevant for patent-cliff and LOE planning.

Key facts

Grant date
Expiration
Claims
CPC classes
A61K 9/ 00 A I, A61K 9/ 127 A I, A61K 31/ 409 A I, A61K 41/ 00 A I, A61K 47/ 48 A I, A61K 49/ 00 A I

More from ALBRECHT VOLKER [DE]

Related pharmaceutical patents in our USPTO index.

  1. BR PI0714667

    conjugado molecular e respectivo uso

    CERAMOPTEC IND INC [US] · Expires Aug 1, 2033

    granted
  2. MX 2013000877

    APPLICATION OF β-FUNCTIONALIZED DIHYDROXY-CHLORINS FOR PDT.

    BIOLITEC PHARMA MARKETING LTD [MY] · Expires Jun 28, 2033

    granted
  3. US 2013041307

    APPLICATION OF BETA-FUNCTIONALIZED DIHYDROXY-CHLORINS FOR PDT

    CERAMOPTEC IND INC [DE] · Expires Feb 9, 2033

    granted
  4. WO 2013015774

    DIHYDROXY-CHLORINES GLYCO-SUBSTITUÉES ET CHLORINES BÊTA-FONCTIONNALISÉES POUR THÉRAPIE ANTIMICROBIENNE PHOTODYNAMIQUE

    BIOLITEC PHARMA MARKETING LTD [MY] · Expires Jan 26, 2033

    granted
  5. BR PI0614453

    método de redução de cululite indesejada em áreas seletivas de um organismo e mistura fotossensibilizante

    CERAMOPTEC IND INC [US] · Expires Dec 6, 2032

    granted
  6. US 2012263625

    GLYCO-SUBSTITUTED DIHYDROXY-CHLORINS AND ß-FUNCTIONALIZED CHLORINS FOR ANTI-MICROBIAL PHOTODYNAMIC THERAPY

    AICHER DANIEL [DE] · Expires Oct 13, 2032

    granted
  7. US 2012259187

    DYNAMIC COLORECTAL PDT APPLICATION

    KRUIJT BASTIAAN [NL] · Expires Oct 6, 2032

    granted
  8. US 2011206613

    METHOD AND APPLICATION OF UNSYMMETRICALLY meso-SUBSTITUTED PORPHYRINS AND CHLORINS FOR PDT

    WIEHE ARNO [DE] · Expires Aug 20, 2031

    granted

Frequently asked questions

What is US patent 2010247626?

US 2010247626 (PEGYLATED COMPOUNDS FOR AGE-RELATED MACULAR DEGENERATION) is held by ALBRECHT VOLKER [DE]. Status: granted. Granted Sep 30, 2010. Expires Sep 25, 2030 (4 years remaining) — relevant for patent-cliff and LOE planning.

Who owns US 2010247626?

ALBRECHT VOLKER [DE] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 25 pharmaceutical patents for this assignee.

When does US 2010247626 expire?

Our index shows an expiration date of Sep 25, 2030 (4 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.